Operating cash flow decreased 66.0%
Operating cash flow changed -66.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$37.4M→$12.7M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CDNA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital / assets moved 1813 bp lower
Working capital / assets changed -1813 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
46.55%→28.42%4 prior comparisons
Inventory decreased 67.7%
Inventory changed -67.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$28.3M→$9.1M4 prior comparisons
Revenue increased 39.3%
Revenue changed +39.3% from the comparable as-filed period.
$100.1M→$139.4M2 prior comparisons
Operating margin moved 607 bp higher
Operating margin changed +607 basis points from the comparable as-filed period.
-0.25%→5.82%2 prior comparisons
Cash & equivalents increased 173.9%
Cash & equivalents changed +173.9% from the comparable as-filed period.
$91.4M→$250.5M2 prior comparisons
Research & development increased 27.2%
Research & development changed +27.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$16.8M→$21.3M2 prior comparisons
Total assets increased 20.0%
Total assets changed +20.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$444.3M→$533.0M4 prior comparisons
Working capital / assets moved 1476 bp higher
Working capital / assets changed +1476 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
48.20%→62.95%4 prior comparisons
Operating cash flow increased 209.3%
Operating cash flow changed +209.3% from the comparable as-filed period.
$9.9M→$30.6M3 prior comparisons
Revenue increased 52.2%
Revenue changed +52.2% from the comparable as-filed period.
$86.7M→$131.9M2 prior comparisons
Operating margin moved 9864 bp higher
Operating margin changed +9864 basis points from the comparable as-filed period.
-12.83%→85.81%2 prior comparisons
Research & development increased 33.0%
Research & development changed +33.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$16.8M→$22.4M2 prior comparisons
Cash & equivalents increased 447.8%
Cash & equivalents changed +447.8% from the comparable as-filed period.
$68.2M→$373.6M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.